Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy
Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy - - IDENTIFYING SUITABLE CYTOSTATIC DRUGS FOR COMBINATORIAL IMMUNOTHERAPY The main dilemma in finding combinations of cytostatic and immunostimulatory drugs that act synerg...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
October 2020
|
| In: |
Cell stress
Year: 2020, Volume: 4, Issue: 10, Pages: 248-251 |
| ISSN: | 2523-0204 |
| DOI: | 10.15698/cst2020.10.233 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.15698/cst2020.10.233 Verlag, kostenfrei, Volltext: https://www.cell-stress.com/researcharticles/2020a-baumann-cell-stress/ 
|
| Author Notes: | Daniel Baumann and Rienk Offringa |
MARC
| LEADER | 00000naa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1927794897 | ||
| 003 | DE-627 | ||
| 005 | 20250606120153.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250606s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.15698/cst2020.10.233 |2 doi | |
| 035 | |a (DE-627)1927794897 | ||
| 035 | |a (DE-599)KXP1927794897 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Baumann, Daniel |e VerfasserIn |0 (DE-588)1186002131 |0 (DE-627)1665288558 |4 aut | |
| 245 | 1 | 0 | |a Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy |c Daniel Baumann and Rienk Offringa |
| 264 | 1 | |c October 2020 | |
| 300 | |b Illustrationen | ||
| 300 | |a 4 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.06.2025 | ||
| 520 | |a Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy - - IDENTIFYING SUITABLE CYTOSTATIC DRUGS FOR COMBINATORIAL IMMUNOTHERAPY The main dilemma in finding combinations of cytostatic and immunostimulatory drugs that act synergistically is as follows. On the one hand, the aim is to induce tumor cell death, not merely stasis, thereby feeding the immune system with tumor antigen. On the other hand, it is essential not to (...) | ||
| 700 | 1 | |a Offringa, Rienk |e VerfasserIn |0 (DE-588)1066807485 |0 (DE-627)817963391 |0 (DE-576)426161424 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell stress |d Graz : Shared Science Publishers, 2017 |g 4(2020), 10 vom: Okt., Seite 248-251 |h Online-Ressource |w (DE-627)1009895931 |w (DE-600)2915581-2 |w (DE-576)496791818 |x 2523-0204 |7 nnas |a Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy |
| 773 | 1 | 8 | |g volume:4 |g year:2020 |g number:10 |g month:10 |g pages:248-251 |g extent:4 |a Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy |
| 856 | 4 | 0 | |u https://doi.org/10.15698/cst2020.10.233 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.cell-stress.com/researcharticles/2020a-baumann-cell-stress/ |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250606 | ||
| 993 | |a Article | ||
| 994 | |a 2020 | ||
| 998 | |g 1066807485 |a Offringa, Rienk |m 1066807485:Offringa, Rienk |d 910000 |d 910200 |e 910000PO1066807485 |e 910200PO1066807485 |k 0/910000/ |k 1/910000/910200/ |p 2 |y j | ||
| 998 | |g 1186002131 |a Baumann, Daniel |m 1186002131:Baumann, Daniel |d 910000 |d 910200 |e 910000PB1186002131 |e 910200PB1186002131 |k 0/910000/ |k 1/910000/910200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1927794897 |e 4732025447 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"relHost":[{"origin":[{"publisherPlace":"Graz","publisher":"Shared Science Publishers","dateIssuedDisp":"[2017]-"}],"id":{"issn":["2523-0204"],"eki":["1009895931"],"zdb":["2915581-2"]},"part":{"volume":"4","extent":"4","issue":"10","pages":"248-251","text":"4(2020), 10 vom: Okt., Seite 248-251","year":"2020"},"type":{"media":"Online-Ressource","bibl":"periodical"},"title":[{"title":"Cell stress","title_sort":"Cell stress","subtitle":"the journal of the European Research Institute for Integrated Cellular Pathology"}],"disp":"Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapyCell stress","physDesc":[{"extent":"Online-Ressource"}],"recId":"1009895931","pubHistory":["Volume 1, issue 1 (October 2017)-"],"language":["eng"]}],"physDesc":[{"extent":"4 S.","noteIll":"Illustrationen"}],"recId":"1927794897","note":["Gesehen am 06.06.2025"],"language":["eng"],"origin":[{"dateIssuedDisp":"October 2020","dateIssuedKey":"2020"}],"id":{"doi":["10.15698/cst2020.10.233"],"eki":["1927794897"]},"person":[{"given":"Daniel","family":"Baumann","display":"Baumann, Daniel","role":"aut"},{"role":"aut","display":"Offringa, Rienk","family":"Offringa","given":"Rienk"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Daniel Baumann and Rienk Offringa"]},"title":[{"title_sort":"Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy","title":"Targeting immune-checkpoint inhibitor resistance mechanisms by MEK inhibitor and agonist anti-CD40 antibody combination therapy"}]} | ||
| SRT | |a BAUMANNDANTARGETINGI2020 | ||